MHRA announces new recognition routes for new medicines

The Medicines and Healthcare products Regulatory Agency has announced a new challenge for artificial intelligence and machine learning developers, to build models that can predict heart failure-related health outcomes for veterans.

The competition is a a collaboration between regulators and healthcare organisations in the UK and US.

The Veterans Cardiac Health and AI Model Predictions (V-CHAMPs) Challenge has been launched by the VHA Innovation Ecosystem, the FDA Digital Health Center of Excellence, precisionFDA (part of the FDA’s Office of Digital Transformation) and the Medicines and Healthcare products Regulatory Agency (MHRA).

Participants will use entirely synthetic datasets based on real US veteran health records to explore a range of potential outcomes following heart failure, including the prediction of cardiovascular outcomes, hospital readmission rates and mortality.

The competition is intended to help health systems both in the US and the UK to better understand the cardiovascular risks and specific health outcomes in veterans, as well as increasing understanding of synthetic data and AI/ML models and how they could be used to explore similar topics in the future.

Paul Campbell, interim head of software at the MHRA, said: "This is a unique chance for any developer or team to get involved, challenge themselves against other experts across the globe, all while contributing towards a worthy goal.

"Having access to hi-fidelity synthetic datasets will be a game-changer in this space, offering an opportunity for participants to test the potential of synthetic data to its limits.

"I’m so pleased to be able to work with our US partners, bringing together cutting-edge health data expertise from both sides of the Atlantic, and I can’t wait to see what the contestants build with this data."

Image by Gerd Altmann from Pixabay